Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01546207 · ClinicalTrials.gov registry record · NA

Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia

A NA study, sponsored by Vivek Reddy.

Terminated
Registry status
NA
Development phase
4
Enrollment target

NCT01546207: Clinical Trial NA study, sponsored by Vivek Reddy.

NCT01546207 is a NA study that was terminated before completion, run by Vivek Reddy. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01546207, a NA study, was terminated before completion, sponsored by Vivek Reddy.

TERMINATED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

The goal of this trial is to test the impact of a step-wise approach for catheter ablation of recurrent ventricular tachycardia, (irregular heart rhythms that originate in the bottom chambers of the heart), in patients with a previous heart attack for whom catheter ablation is clinically indicated.

Primary Outcome

The procedural efficacy as defined as acute success of a standardized step-wise approach for substrate-based catheter ablation of recurrent ventricular tachycardia in patients with coronary artery disease and prior ventricular tachycardia or appropriate therapy. Acute success will be defined as the ability to render VT non-inducible with a standardized complete stimulation protocol. catheter ablation - a medical procedure used to treat some types of arrhythmia

Interventions

  • PROCEDURE catheter-based ablation

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2011-09
Est. Completion 2013-08
Phase NA
Vivek Reddy

20 total trials

Why NCT01546207 stopped before completion

NCT01546207 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which catheter-based ablation is the first listed.

NCT01546207 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01546207 about?

NCT01546207 is a clinical study titled "Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia". The goal of this trial is to test the impact of a step-wise approach for catheter ablation of recurrent ventricular tachycardia, (irregular heart rhythms that originate in the bottom chambers of the heart), in patients with a previous heart attack for whom catheter ablation is clinically indicated.

What is the current status of trial NCT01546207?

This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2011-09. Estimated completion is 2013-08.

What interventions are being tested in trial NCT01546207?

The interventions under investigation include: catheter-based ablation (PROCEDURE).

Who is sponsoring clinical trial NCT01546207?

This trial is sponsored by Vivek Reddy, which has 20 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01546207's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01546207, the US trial registry maintained by the National Library of Medicine. NCT01546207 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.